ask="N/A"
ask_size="N/A"
average_daily_volume="525100"
bid="N/A"
bid_size="N/A"
book_value="0.30"
change="+0.06"
change_from_200_day_moving_average="0.21"
change_from_50_day_moving_average="0.43"
change_from_52_week_high="-0.87"
change_From_52_week_low="0.63"
change_in_percent="+4.20%"
close="1.49"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.54"
ebitda="-24.87M"
eps_estimate_current_year="-0.48"
eps_estimate_next_quarter="-0.15"
eps_estimate_next_year="-0.35"
ex_dividend_date="N/A"
float_shares="50898000"
high="1.49"
high_52_weeks="2.36"
last_trade_date="2/17/2017"
last_trade_price="1.49"
last_trade_size="21289"
last_trade_time="4:02pm"
low="1.39"
low_52_weeks="0.86"
market_capitalization="83.06M"
moving_average_200_day="1.28"
moving_average_50_day="1.06"
name="Actinium Pharmaceuticals
Inc. "
notes="N/A"
one_year_target_price="7.33"
open="1.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+16.51%"
percent_change_from_50_day_moving_average="+39.97%"
percent_change_from_52_week_high="-36.86%"
percent_change_from_52_week_low="+73.26%"
previous_close="1.43"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.80"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="55747000"
short_ratio="3.55"
stock_exchange="ASE"
symbol="ATNM"
volume="483774"
weeks_range_52="0.86 - 2.36"
